HGSNAT

Chr 8AR

heparan-alpha-glucosaminide N-acetyltransferase

Also known as: HGNAT, MPS3C, RP73, TMEM76

This protein functions as a lysosomal acetyltransferase essential for heparan sulfate degradation. Mutations cause mucopolysaccharidosis type IIIC (Sanfilippo syndrome C), a lysosomal storage disorder resulting from impaired heparan sulfate breakdown, and retinitis pigmentosa 73, both inherited in an autosomal recessive pattern. The pathogenic mechanism involves deficient enzymatic activity leading to toxic accumulation of undegraded heparan sulfate in lysosomes.

GeneReviewsOMIMResearchSummary from RefSeq, OMIM, UniProt
LOFmechanismARLOEUF 0.732 OMIM phenotypes
Clinical SummaryHGSNAT
🧬
Gene-Disease Validity (ClinGen)
inherited retinal dystrophy · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

2 total gene-disease associations curated

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
89 unique Pathogenic / Likely Pathogenic· 157 VUS of 500 total submissions
📖
GeneReview available — HGSNAT
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.73LOEUF
pLI 0.000
Z-score 2.85
OE 0.49 (0.340.73)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
0.71Z-score
OE missense 0.89 (0.810.98)
283 obs / 318.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.49 (0.340.73)
00.351.4
Missense OE0.89 (0.810.98)
00.61.4
Synonymous OE0.99
01.21.6
LoF obs/exp: 18 / 36.6Missense obs/exp: 283 / 318.5Syn Z: 0.05
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveHGSNAT-related mucopolysaccharidosis type IIICLOFAR
limitedHGSNAT-related retinitis pigmentosaOTHERAR

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.6454th %ile
GOF
0.6151th %ile
LOF
0.3066th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

500 submitted variants in ClinVar

Classification Summary

Pathogenic39
Likely Pathogenic50
VUS157
Likely Benign232
Benign5
Conflicting3
39
Pathogenic
50
Likely Pathogenic
157
VUS
232
Likely Benign
5
Benign
3
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
25
0
14
0
39
Likely Pathogenic
37
10
3
0
50
VUS
1
113
36
7
157
Likely Benign
0
2
137
93
232
Benign
0
1
4
0
5
Conflicting
3
Total63126194100486

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

HGSNAT · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →